Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | PDE5A | O76074 | 4/20 | 0.49 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.49 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9847122 | 0.92 | GPR35 (0.54) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11109052 | 0.90 | GPR35 (0.54) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11285738 | 0.90 | GPR35 (0.42) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11284294 | 0.89 | MEN1 (0.53) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11288378 | 0.89 | PDE5A (0.44) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11111213 | 0.88 | MAPK1 (0.45) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11314373 | 0.86 | GPR35 (0.44) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11289881 | 0.86 | KDM4E (0.38) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11392900 | 0.86 | GPR35 (0.39) | GPR35LMNATDP1PDE5ACYSLTR2 | |
| SCHEMBL11114405 | 0.86 | GPR35 (0.53) | GPR35LMNATDP1PDE5ACYSLTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255969-A1 | TARGETING IMMUNE PATHOLOGIES INDUCED BY HIGHLY PATHOGENIC CORONAVIRUSES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-08-17 | — | — | US | claimed |
| EP-4185286-A1 | TARGETING IMMUNE PATHOLOGIES INDUCED BY HIGHLY PATHOGENIC CORONAVIRUSES | National University of Singapore (SG) | 2023-05-31 | — | — | EP | claimed |
| WO-2022019828-A1 | TARGETING IMMUNE PATHOLOGIES INDUCED BY HIGHLY PATHOGENIC CORONAVIRUSES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2022-01-27 | — | — | WO | claimed |
| US-4232012-A | Composition | FISONS LIMITED (GB) | 1980-11-04 | — | — | US | claimed |
| US-4211777-A | GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1980-07-08 | — | — | US | claimed |
| US-4151292-A | ANTIINFLAMMATORY SIDE EFFECT INHIBITION USING CHROMENE DERIVATIVES, GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1979-04-24 | — | — | US | claimed |
| US-20230255969-A1 | TARGETING IMMUNE PATHOLOGIES INDUCED BY HIGHLY PATHOGENIC CORONAVIRUSES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-08-17 | — | — | US | disclosed |
| EP-4185286-A1 | TARGETING IMMUNE PATHOLOGIES INDUCED BY HIGHLY PATHOGENIC CORONAVIRUSES | National University of Singapore (SG) | 2023-05-31 | — | — | EP | disclosed |
| WO-2022019828-A1 | TARGETING IMMUNE PATHOLOGIES INDUCED BY HIGHLY PATHOGENIC CORONAVIRUSES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2022-01-27 | — | — | WO | disclosed |
| EP-0104018-A2 | Benzopyran, benzothiapyran and quinoline compounds and pharmaceutical compositions containing them | FISONS plc (GB) | 1984-03-28 | — | — | EP | disclosed |
| US-4336194-A | Benzyl pyrrolyl methyl carboxylate insecticides and acaricides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-06-22 | — | — | US | disclosed |
| US-4335048-A | ANTIASTHMA | FISONS LIMITED (GB) | 1982-06-15 | — | — | US | disclosed |
| US-4335048-A | ANTIASTHMA | FISONS LIMITED (GB) | 1982-06-15 | — | — | US | disclosed |
| EP-0040489-A1 | Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine | FISONS plc (GB) | 1981-11-25 | — | — | EP | disclosed |
| US-4232012-A | Composition | FISONS LIMITED (GB) | 1980-11-04 | — | — | US | disclosed |
| US-4232012-A | Composition | FISONS LIMITED (GB) | 1980-11-04 | — | — | US | disclosed |
| US-4211777-A | GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1980-07-08 | — | — | US | disclosed |
| US-4151292-A | ANTIINFLAMMATORY SIDE EFFECT INHIBITION USING CHROMENE DERIVATIVES, GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1979-04-24 | — | — | US | disclosed |
| US-4151292-A | ANTIINFLAMMATORY SIDE EFFECT INHIBITION USING CHROMENE DERIVATIVES, GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1979-04-24 | — | — | US | disclosed |